NLM Digital Collections

Search

Start Over Subjects Drug Costs ✖Remove constraint Subjects: Drug Costs

61. The effect of Medicare Part D on evergreening, generic entry, and drug prices

Author(s):
Sanzenbacher, Geoffrey T., author
Wettstein, Gal, author
Publication:
Chestnut Hill, MA : Center for Retirement Research at Boston College, May 2019
Subject(s):
Drug Costs
Drugs, Generic -- economics
Medicare Part D -- economics
Patents as Topic
Aged
Drug Industry -- economics
Economics, Pharmaceutical
Humans
United States
United States. Food and Drug Administration.
Medical Expenditure Panel Survey (U.S.)

64. Quality of healthcare

Author(s):
Brude, Sydney, author
White, Robert S., author
Publication:
[Toronto, Ontario] : Thomson Reuters, 23-December-2019
Subject(s):
Legislation, Medical
Patient Safety -- legislation & jurisprudence
Quality of Health Care -- legislation & jurisprudence
Ambulatory Care Facilities -- legislation & jurisprudence
Drug Costs
Elder Abuse
Equipment Failure
Equipment Safety
Health Facilities -- legislation & jurisprudence
Legislation, Hospital
Medicare
Nursing Homes -- legislation & jurisprudence
Quality Indicators, Health Care -- legislation & jurisprudence
State Government
Surgicenters
Veterans Health
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

65. Administrative rulemaking

Author(s):
Berry, Melissa D., author
Publication:
[Toronto, Ontario] : Thomson Reuters, 23-December-2019
Subject(s):
Health Care Reform -- legislation & jurisprudence
Advertising -- legislation & jurisprudence
Conscientious Refusal to Treat -- legislation & jurisprudence
Contraception
Drug Costs
Emergency Medical Services -- legislation & jurisprudence
Emigrants and Immigrants -- legislation & jurisprudence
Hospital Costs
Insurance, Health, Reimbursement
Long-Term Care
Medicaid -- legislation & jurisprudence
Medicare -- legislation & jurisprudence
Politics
Taxes
Transportation of Patients -- legislation & jurisprudence
Humans
United States
United States. Department of Health and Human Services.
United States.
Centers for Medicare & Medicaid Services (U.S.)

66. Insurance market reform:

Publication:
[Toronto, Ontario] : Thomson Reuters, 23-December-2019
Subject(s):
Health Care Reform -- economics
Health Care Reform -- legislation & jurisprudence
Health Care Reform -- trends
Health Insurance Exchanges -- economics
Health Insurance Exchanges -- legislation & jurisprudence
Health Insurance Exchanges -- trends
Insurance, Health -- economics
Insurance, Health -- legislation & jurisprudence
Insurance, Health -- trends
Drug Costs
Forecasting
Federal Government
Medicaid
State Government
Humans
United States
United States.
Centers for Medicare & Medicaid Services (U.S.)

67. Medicare Part D

Author(s):
Steiner, David J., author
Publication:
[Toronto, Ontario] : Thomson Reuters, 23-December-2019
Subject(s):
Drug Costs
Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
Biosimilar Pharmaceuticals -- economics
Cost Control -- legislation & jurisprudence
Drugs, Generic -- economics
Economics, Pharmaceutical
Financing, Personal
Fraud
Legislation, Drug
Medicare Part C
Opioid-Related Disorders
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

68. Drug discount program: status of agency efforts to improve 340B program oversight : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, May 15, 2018
Subject(s):
Drug Costs
Economics, Pharmaceutical
Government Regulation
Medicaid -- economics
United States
United States. Health Resources and Services Administration.

70. Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, July 11, 2018
Subject(s):
Drug Costs
Economics, Pharmaceutical
Pharmacies -- economics
Contract Services
Government Regulation
United States
United States. Health Resources and Services Administration.